SAN DIEGO, Aug. 18, 2011 /PRNewswire/ -- Mentor Capital, Inc. (OTC Markets: MNTR) announced today that confidential discussions have been initiated that could lead to a merger, acquisition or very significant investment with a medically related entity. Mentor Capital's role in this transaction is to provide up to $100 Million in equity funding to support the growth and acquisition interests of the medical company.
Additional shareholder communication will be forthcoming to report on the progress of any negotiations in the transaction process.
Mentor Capital has focused its efforts on providing acquisition or investment funding for leading-edge cancer fighting companies as detailed on the Mentor Capital website.
Forward Looking Statements, Safe Harbor and Risk Descriptions are Incorporated by Reference from the MNTR Company Web Site above.
For further information contact:
Chester Billingsley, CEO
Mentor Capital, Inc.
(760) 788 - 4700
SOURCE Mentor Capital, Inc.
NEXT ARTICLE